A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body

Status:	Terminated
Conditions:	Lung Cancer, Colorectal Cancer, Skin Cancer, Cancer, Cancer
Therapuetic Areas:	Oncology
Healthy:	No
Age Range:	18 - Any
Updated:	2/27/2019
Start Date:	November 26, 2013
End Date:	October 5, 2018

A Phase 1 Study of LY3009120 in Patients With Advanced or Metastatic Cancer

The main purpose of this study is to see how safe the investigational drug known as LY3009120
is and whether it will work to help people with advanced cancer or cancer that has spread to
other parts of the body.

Inclusion Criteria:

- Advanced or metastatic cancer

- Other available therapies have failed to cure the cancer

- The cancer that has no proven effective therapy

- The cancer can be biopsied (depending on the tumor type and/or the dose of drug
received, tumor biopsies may be required)

- Able to swallow capsules

Exclusion Criteria:

- Have active cancer in the brain or spinal cord

- Have an active infection of any kind (fungal, viral, or bacterial)

- Have a cancer of the blood

- Are pregnant or breastfeeding

- Have some types of eye problems or impairments

We found this trial at

sites

Massachusetts General Hospital

185 Cambridge Street
Boston, Massachusetts 02114

617-724-5200